AivoCode has been awarded a Phase I SBIR grant from NINDS at NIH for developing therapies for treating moderate-severe traumatic brain injury. The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are highly competitive programs that encourage domestic small businesses to engage in Federal Research/Research and Development (R/R&D) with the potential for commercialization.
AivoCode Awarded NIH Grant to Develop a Novel Therapeutic for Traumatic Brain Injury
Previous
Previous
Awarded NIH Grant to Develop Therapies for Alzheimer’s Disease
Next
Next